Download Files:
Spartalizumab
Price range: 285 CAD through 1,467 CAD
Products Details
Product Description
– Spartalizumab (PDR001) is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to PD-1 at low concentrations, exhibiting high activity. It blocks the interaction with PD-L1 and PD-L2, making it suitable for studying undifferentiated thyroid cancer (ATC).
Web ID
– T77075
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Jaume Capdevila, et al. PD-1 Blockade in Anaplastic Thyroid Carcinoma. J Clin Oncol. 2020 Aug 10;38(23):2620-2627.
CAS Number
– 1935694-88-4
Molecular Weight
Compound Purity
– 96.3% (SEC-HPLC)
Pathway
– Cell Cycle/Checkpoint|||Immunology/Inflammation|||Apoptosis
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
